EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Selective Mycobacterium tuberculosis Shikimate Kinase Inhibitors as Potential Antibacterials

Sara Gordon, Johayra Simithy, Douglas C Goodwin, Angela I Calderón

Perspectives in Medicinal Chemistry · 2015

DOI: 10.4137/pmc.s13212 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Perspectives in Medicinal Chemistry, 2015. Verfasst von Sara Gordon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL, USA. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Owing to the persistence of tuberculosis (TB) as well as the emergence of multidrug-resistant and extensively drug-resistant (XDR) forms of the disease, the development of new antitubercular drugs is crucial. Developing inhibitors of shikimate kinase (SK) in the shikimate pathway will provide a selective target for antitubercular agents. Many studies have used in silico technology to identify compounds that are anticipated to interact with and inhibit SK. To a much more limited extent, SK inhibition has been evaluated by in vitro methods with purified enzyme. Currently, there are no data on in vivo activity of Mycobacterium tuberculosis shikimate kinase ( MtSK) inhibitors available in the literature. In this review, we present a summary of the progress of SK inhibitor discovery and evaluation with particular attention toward development of new antitubercular agents.

Schlagwörter

Stichwörter der Autor:innen

Mycobacterium tuberculosisantitubercularshikimate kinase inhibitors

Autor:innen und Institutionen

  • Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL, USA.
  • Department of Chemistry and Biochemistry, Auburn University, Auburn, AL, USA.

Zitieren

APA

Gordon, S., Simithy, J., Goodwin, D. C., & Calderón, A. I. (2015). Selective Mycobacterium tuberculosis Shikimate Kinase Inhibitors as Potential Antibacterials. Perspectives in Medicinal Chemistry. https://doi.org/10.4137/pmc.s13212

Vancouver

Gordon S, Simithy J, Goodwin DC, Calderón AI. Selective Mycobacterium tuberculosis Shikimate Kinase Inhibitors as Potential Antibacterials. Perspectives in Medicinal Chemistry. 2015. doi:10.4137/pmc.s13212

BibTeX
@article{Gordon2015,
  author = {Gordon, Sara and Simithy, Johayra and Goodwin, Douglas C and Calderón, Angela I},
  title = {Selective Mycobacterium tuberculosis Shikimate Kinase Inhibitors as Potential Antibacterials},
  journal = {Perspectives in Medicinal Chemistry},
  year = {2015},
  doi = {10.4137/pmc.s13212}
}
Kostenlos starten →